These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 2614934

  • 1. Direct chronotropic and inotropic effects of mildronate using cross-circulated dog atrial and ventricular preparations.
    Chiba S, Akahane K, Furukawa Y, Karasawa Y.
    Jpn Heart J; 1989 Sep; 30(5):743-50. PubMed ID: 2614934
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cardiovascular effects of a new phenoxyalkylamine derivative, 2-isopropyl-5-[3-(2-methoxyphenoxy)propylamino]-2-(3,4,5-trimethoxy phenyl) valeronitrile fumarate (HV-525), in cross-circulated dog atrial preparations.
    Chiba S, Ogiwara Y, Furukawa Y, Saegusa K.
    Jpn Heart J; 1987 Mar; 28(2):261-72. PubMed ID: 3599413
    [Abstract] [Full Text] [Related]

  • 4. Effects of magnesium on the isolated, blood-perfused atrial and ventricular preparations of the dog heart.
    Furukawa Y, Chiba S.
    Jpn Heart J; 1981 Mar; 22(2):239-46. PubMed ID: 7230523
    [Abstract] [Full Text] [Related]

  • 5. Cardiovascular effects of methylflavonolamine hydrochloride (SIPI-549) in cross-circulated canine atrial and ventricular preparations.
    Chiba S, Akabane K, Furukawa Y, Karasawa Y.
    Jpn Heart J; 1989 Jul; 30(4):511-21. PubMed ID: 2572710
    [Abstract] [Full Text] [Related]

  • 6. Positive inotropic and negative chronotropic effects of OPC-8490, a newly developed cardiotonic, in isolated, blood-perfused canine heart preparations.
    Furukawa Y, Akahane K, Haniuda M, Chiba S.
    Jpn Heart J; 1989 May; 30(3):387-98. PubMed ID: 2552190
    [Abstract] [Full Text] [Related]

  • 7. Bradycardic effect of alinidine on in situ and on isolated, blood-perfused heart preparations of dogs.
    Ogiwara Y, Furukawa Y, Saegusa K, Takeda M, Chiba S.
    Arch Int Pharmacodyn Ther; 1988 May; 291():41-54. PubMed ID: 2835022
    [Abstract] [Full Text] [Related]

  • 8. Cardiac effects of vecuronium and its interaction with autonomic nervous system in isolated perfused canine hearts.
    Narita M, Furukawa Y, Ren LM, Karasawa Y, Takei M, Murakami M, Takayama S, Chiba S.
    J Cardiovasc Pharmacol; 1992 Jun; 19(6):1000-8. PubMed ID: 1376800
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cardiac effects of YM-09538, a new alpha- and beta-adrenoceptor blocking agent, on SA nodal pacemaker activity and contractility in isolated atria and intact dogs.
    Chiba S, Watanabe H, Furukawa Y, Iwatsuki K.
    Jpn Heart J; 1982 Jul; 23(4):631-6. PubMed ID: 6127420
    [Abstract] [Full Text] [Related]

  • 15. Positive chronotropic and inotropic effects of pimobendan (UD-CG 115 BS) in isolated, cross-circulated canine heart preparations.
    Furukawa Y, Akahane K, Ogiwara Y, Haniuda M, Chiba S.
    Arch Int Pharmacodyn Ther; 1989 Jul; 300():159-73. PubMed ID: 2575887
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.